Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network

Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network

Background: The addition of immune checkpoint inhibitors (ICIs) and antibody–drug conjugates into the metastatic urothelial cancer (mUC) treatment landscape has advanced therapeutic strategies beyond platinum-based chemotherapy (PBT). We evaluated real-world treatment patterns and overall survival (...

Full description

Saved in:
Bibliographic Details
Main Authors: H. Li, S. Sura, A. Babcock, L. Herms, J. Guo, P. Conkling, S. Franco, P. Singhal, R. Mamtani, M. Bupathi
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:ESMO Real World Data and Digital Oncology
Subjects:
metastatic urothelial cancer
maintenance therapy
treatment patterns
overall survival
avelumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2949820124000882
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2949820124000882

Similar Items